Reward Mechanisms in Obesity
NCT03347890
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml or Placebo
Sponsor
Zoltan Pataky
Collaborators
[object Object]